Angiotensin ii acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for angiotensin ii acetate and what is the scope of patent protection?
Angiotensin ii acetate
is the generic ingredient in two branded drugs marketed by Gland and La Jolla Pharma, and is included in two NDAs. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Angiotensin ii acetate has fifty-two patent family members in twenty-four countries.
Two suppliers are listed for this compound.
Summary for angiotensin ii acetate
International Patents: | 52 |
US Patents: | 11 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Clinical Trials: | 6 |
Patent Applications: | 68 |
DailyMed Link: | angiotensin ii acetate at DailyMed |
Recent Clinical Trials for angiotensin ii acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kasr El Aini Hospital | N/A |
American Lung Association | Phase 2 |
Johns Hopkins University | Phase 2 |
Pharmacology for angiotensin ii acetate
Drug Class | Vasoconstrictor |
Physiological Effect | Vasoconstriction |
Medical Subject Heading (MeSH) Categories for angiotensin ii acetate
Anatomical Therapeutic Chemical (ATC) Classes for angiotensin ii acetate
Paragraph IV (Patent) Challenges for ANGIOTENSIN II ACETATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
GIAPREZA | Injection | angiotensin ii acetate | 2.5 mg/mL | 209360 | 1 | 2021-12-21 |
US Patents and Regulatory Information for angiotensin ii acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 11,559,559 | ⤷ Try for Free | ⤷ Try for Free | ||||
La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | 10,500,247 | ⤷ Try for Free | ⤷ Try for Free | ||||
La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | 9,867,863 | ⤷ Try for Free | ⤷ Try for Free | ||||
La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 11,096,983 | ⤷ Try for Free | ⤷ Try for Free | ||||
La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 9,867,863 | ⤷ Try for Free | ⤷ Try for Free | ||||
La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | AP | RX | Yes | Yes | 10,493,124 | ⤷ Try for Free | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for angiotensin ii acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2986308 | ANGIOTENSINE II EN ASSOCIATION POUR LE TRAITEMENT DE L'HYPERTENSION (ANGIOTENSIN II IN COMBINATION FOR THE TREATMENT OF HYPOTENSION) | ⤷ Try for Free |
Poland | 2986308 | ⤷ Try for Free | |
Lithuania | 2986308 | ⤷ Try for Free | |
World Intellectual Property Organization (WIPO) | 2017120438 | ⤷ Try for Free | |
China | 112546197 | 血管紧张素II单独或以组合方式用于治疗低血压 (Angiotensin ll alone or in combination for the treatment of hypotension) | ⤷ Try for Free |
Australia | 2020277230 | Angiotensin ll alone or in combination for the treatment of hypotension | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Angiotensin II Acetate: Market Dynamics and Financial Trajectory
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.